Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Dermatologic 1

Conditions

Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sezary Syndrome 1Sarcoma, Kaposi 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Penile Neoplasms 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mycosis Fungoides 1Mouth Neoplasms 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

tin etiopurpurin 1Tumor Necrosis Factor-alpha 1Semaxinib 1Ritonavir 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Ritonavir × Dermatologic × Clear all
NCT00002366 2009-02-20

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Abbott

Phase 2 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡